The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life (QOL), financial burden, and perception of care in patients enrolled on clinical trials (CTs).
 
Surbhi Sidana
Consulting or Advisory Role - Janssen
 
Cristine Allmer
No Relationships to Disclose
 
Melissa C. Larson
No Relationships to Disclose
 
Amylou C. Dueck
Consulting or Advisory Role - Bayer; Phytogine
 
Kathleen J. Yost
No Relationships to Disclose
 
Rahma M. Warsame
No Relationships to Disclose
 
Gita Thanarajasingam
No Relationships to Disclose
 
James Robert Cerhan
Consulting or Advisory Role - Janssen; Janssen
Research Funding - Celgene; NanoString Technologies
 
Jonas Paludo
Research Funding - Celgene (Inst)
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date
 
Thomas Matthew Habermann
Consulting or Advisory Role - Celgene; Kite/Gilead
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Morie A. Gertz
Honoraria - Abbvie; Akcea Therapeutics; Amgen; Apellis Pharmaceuticals; Celgene; Med Learning Group; Prothena; Research to Practice
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Thomas E. Witzig
Consulting or Advisory Role - Abbvie/Genentech (Inst); Celgene (Inst); Cellectar; Epizyme; Immune Design; Incyte (Inst); Karyopharm Therapeutics; MorphoSys (Inst); Portola Pharmaceuticals; Seagen (Inst); Tessa Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Kura Oncology (Inst)
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Wilson I. Gonsalves
Consulting or Advisory Role - Amgen (Inst)
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Carrie A. Thompson
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)